Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
Troels Højsgaard JørgensenHans Gustav Hørsted ThyregodMikko SavontausYannick WillemenØyvind BleieMariann TangMatti NiemelaOskar AngeråsIngibjörg J GudmundsdóttirUlrik SartipyHanna DagnegaardMika LaineAndreas RückJarkko PiuholaPetur PeturssonEvald H ChristiansenMarkus MalmbergPeter Skov OlsenRune HaaverstadLars SondergaardOle de Backernull nullPublished in: European heart journal (2024)
Among low-risk patients aged ≤ 75 years with severe symptomatic AS, the rate of the composite of death, stroke, or rehospitalization at one year was similar between TAVI and surgery. TAVI outcomes in young bicuspid AS patients warrant caution and should be further investigated. (NOTION-2, ClinicalTrials.gov, NCT02825134).
Keyphrases
- aortic stenosis
- ejection fraction
- transcatheter aortic valve implantation
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- end stage renal disease
- left ventricular
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- clinical trial
- insulin resistance
- heart failure
- mass spectrometry
- coronary artery bypass
- subarachnoid hemorrhage